NEW YORK (GenomeWeb News) – Funding expectations for 2013 have improved among genomics researchers, despite potential delays or cuts to budgets, according to the latest survey conducted by Mizuho Securities in collaboration with GenomeWeb.

In the survey, which was taken by 93 genomics researchers from academia and industry, respondents expressed a brighter outlook for the genomics space than respondents to similar surveys conducted by Mizuho for the academic and drug discovery end markets, with optimism highest for next-generation sequencing technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.